The case for a medication first approach to the treatment of opioid use disorder-Reference-Cited by-同舟云学术

The case for a medication first approach to the treatment of opioid use disorder

Published:2019-05-14 Issue:4 Volume:45 Page:333-340
ISSN:0095-2990
Container-title:The American Journal of Drug and Alcohol Abuse
language:en
Short-container-title:The American Journal of Drug and Alcohol Abuse

Author:

Winograd Rachel P.¹,Presnall Ned²,Stringfellow Erin¹,Wood Claire¹,Horn Phil¹,Duello Alex¹,Green Lauren¹,Rudder Tim³

Affiliation:

1. Missouri Institute of Mental Health, University of Missouri, St. Louis, USA

2. Clayton Behavioral, Washington University, St. Louis, USA

3. Missouri Department of Mental Health, Jefferson, Missouri, USA

Funder

Substance Abuse and Mental Health Services Administration

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/00952990.2019.1605372

Reference59 articles.

1. Centers for Disease Control and Prevention. HAN00413: rising numbers of feaths involving fentanyl and fentanyl analogs, including carfentanil, and increased usage and mixing with non-opioids [Internet]. Health Alert Network. 2018 [cited 2019 Jan 2]. Available from: https://emergency.cdc.gov/han/han00413.asp

2. Medication-Assisted Treatment of Opioid Use Disorder

3. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

4. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis

5. U.S. Food & Drug Administration Center for Drug Evaluation and Research. Information by drug class - information about medication-assisted treatment (mat) [Internet]. Center for Drug Evaluation and Research; 2018 [cited 2019 Jan 4]. Available from: https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm600092.htm

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Community-Based Medications First for Opioid Use Disorder - Care Utilization and Mortality Outcomes;Substance Abuse and Rehabilitation;2024-09

2. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-09

3. County-level neonatal opioid withdrawal syndrome rates and real-world access to buprenorphine during pregnancy: An audit (“secret shopper”) study in Missouri;Drug and Alcohol Dependence Reports;2024-03

4. Attitudes and Subjective Norms Regarding Medication for Opioid Use Disorder Among Individuals in Treatment for Opioid Use Disorder in the Greater St. Louis Area;Journal of Drug Issues;2024-02-01

5. The association of medical providers’ attitudes about naloxone and treating people with opioid use disorder and their self-reported low-barrier treatment practices;Addictive Behaviors Reports;2023-12